Scott Gerald Meikle - Feb 1, 2022 Form 4 Insider Report for LAM RESEARCH CORP (LRCX)

Role
Senior Vice President
Signature
Leign Cramer by Power of Attorney
Stock symbol
LRCX
Transactions as of
Feb 1, 2022
Transactions value $
-$413,000
Form type
4
Date filed
2/2/2022, 03:38 PM
Previous filing
Dec 16, 2021
Next filing
Feb 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRCX Common Stock Options Exercise $119K +628 +3.69% $190.07 17.7K Feb 1, 2022 Direct F1, F2
transaction LRCX Common Stock Sale -$371K -628 -3.56% $590.00 17K Feb 1, 2022 Direct F1, F2
transaction LRCX Common Stock Options Exercise $12.7K +72 +0.42% $176.75 17.1K Feb 1, 2022 Direct F1, F2
transaction LRCX Common Stock Sale -$42.5K -72 -0.42% $590.00 17K Feb 1, 2022 Direct F1, F2
holding LRCX Common Stock 151 Feb 1, 2022 By 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise -$119K -628 -100% $190.07 0 Feb 1, 2022 Common Stock 628 $190.07 Direct F3
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise -$12.7K -72 -1.13% $176.75 6.3K Feb 1, 2022 Common Stock 72 $176.75 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2021.
F2 The amount reported includes shares subject to unvested Restricted Stock Units.
F3 The stock options will become exercisable in three equal installments on 03/02/2019, 03/02/2020, and 03/02/2021.
F4 The stock options will become exercisable in three equal installments on 03/02/2020, 03/02/2021, and 03/02/2022.